Cargando…
Circulating low density neutrophils of breast cancer patients are associated with their worse prognosis due to the impairment of T cell responses
Neutrophils are prominent immune components of tumors, having either anti-tumor (N1) or pro-tumor activity (N2). Circulating neutrophils, divided into high density neutrophils (HDN) and low density neutrophils (LDN), functionally mirror those N1 and N2 cells, respectively. LDN are rare in non-pathol...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8629401/ https://www.ncbi.nlm.nih.gov/pubmed/34853660 http://dx.doi.org/10.18632/oncotarget.28135 |
_version_ | 1784607198887804928 |
---|---|
author | Saraiva, Diana P. Correia, Bruna F. Salvador, Rute de Sousa, Nídia Jacinto, António Braga, Sofia Cabral, M. Guadalupe |
author_facet | Saraiva, Diana P. Correia, Bruna F. Salvador, Rute de Sousa, Nídia Jacinto, António Braga, Sofia Cabral, M. Guadalupe |
author_sort | Saraiva, Diana P. |
collection | PubMed |
description | Neutrophils are prominent immune components of tumors, having either anti-tumor (N1) or pro-tumor activity (N2). Circulating neutrophils, divided into high density neutrophils (HDN) and low density neutrophils (LDN), functionally mirror those N1 and N2 cells, respectively. LDN are rare in non-pathological conditions, but frequent in cancer, exhibiting a pro-tumor phenotype. These findings have been mainly demonstrated in animal models, thus proper validation in humans is still imperative. Here, we observed that LDN were increased in the blood of breast cancer (BC) patients, particularly with metastatic disease. Within the population of non-metastatic patients, LDN were more prevalent in patients with poor response to neoadjuvant chemotherapy than patients with a good response. The higher incidence of LDN in BC patients with severe disease or resistance to treatment can be explained by their pro-tumor/immunosuppressive characteristics. Moreover, the percentage of LDN in BC patients’ blood was negatively correlated with activated cytotoxic T lymphocytes and positively correlated with immunosuppressive regulatory T cells. The ability of LDN to spoil anti-tumor immune responses was further demonstrated ex vivo. Hence, this study reveals the potential of LDN as a biomarker of BC response to treatment and opens new avenues for developing new immunotherapies. |
format | Online Article Text |
id | pubmed-8629401 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Impact Journals LLC |
record_format | MEDLINE/PubMed |
spelling | pubmed-86294012021-11-30 Circulating low density neutrophils of breast cancer patients are associated with their worse prognosis due to the impairment of T cell responses Saraiva, Diana P. Correia, Bruna F. Salvador, Rute de Sousa, Nídia Jacinto, António Braga, Sofia Cabral, M. Guadalupe Oncotarget Research Paper Neutrophils are prominent immune components of tumors, having either anti-tumor (N1) or pro-tumor activity (N2). Circulating neutrophils, divided into high density neutrophils (HDN) and low density neutrophils (LDN), functionally mirror those N1 and N2 cells, respectively. LDN are rare in non-pathological conditions, but frequent in cancer, exhibiting a pro-tumor phenotype. These findings have been mainly demonstrated in animal models, thus proper validation in humans is still imperative. Here, we observed that LDN were increased in the blood of breast cancer (BC) patients, particularly with metastatic disease. Within the population of non-metastatic patients, LDN were more prevalent in patients with poor response to neoadjuvant chemotherapy than patients with a good response. The higher incidence of LDN in BC patients with severe disease or resistance to treatment can be explained by their pro-tumor/immunosuppressive characteristics. Moreover, the percentage of LDN in BC patients’ blood was negatively correlated with activated cytotoxic T lymphocytes and positively correlated with immunosuppressive regulatory T cells. The ability of LDN to spoil anti-tumor immune responses was further demonstrated ex vivo. Hence, this study reveals the potential of LDN as a biomarker of BC response to treatment and opens new avenues for developing new immunotherapies. Impact Journals LLC 2021-11-23 /pmc/articles/PMC8629401/ /pubmed/34853660 http://dx.doi.org/10.18632/oncotarget.28135 Text en Copyright: © 2021 Saraiva et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/3.0/) (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Paper Saraiva, Diana P. Correia, Bruna F. Salvador, Rute de Sousa, Nídia Jacinto, António Braga, Sofia Cabral, M. Guadalupe Circulating low density neutrophils of breast cancer patients are associated with their worse prognosis due to the impairment of T cell responses |
title | Circulating low density neutrophils of breast cancer patients are associated with their worse prognosis due to the impairment of T cell responses |
title_full | Circulating low density neutrophils of breast cancer patients are associated with their worse prognosis due to the impairment of T cell responses |
title_fullStr | Circulating low density neutrophils of breast cancer patients are associated with their worse prognosis due to the impairment of T cell responses |
title_full_unstemmed | Circulating low density neutrophils of breast cancer patients are associated with their worse prognosis due to the impairment of T cell responses |
title_short | Circulating low density neutrophils of breast cancer patients are associated with their worse prognosis due to the impairment of T cell responses |
title_sort | circulating low density neutrophils of breast cancer patients are associated with their worse prognosis due to the impairment of t cell responses |
topic | Research Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8629401/ https://www.ncbi.nlm.nih.gov/pubmed/34853660 http://dx.doi.org/10.18632/oncotarget.28135 |
work_keys_str_mv | AT saraivadianap circulatinglowdensityneutrophilsofbreastcancerpatientsareassociatedwiththeirworseprognosisduetotheimpairmentoftcellresponses AT correiabrunaf circulatinglowdensityneutrophilsofbreastcancerpatientsareassociatedwiththeirworseprognosisduetotheimpairmentoftcellresponses AT salvadorrute circulatinglowdensityneutrophilsofbreastcancerpatientsareassociatedwiththeirworseprognosisduetotheimpairmentoftcellresponses AT desousanidia circulatinglowdensityneutrophilsofbreastcancerpatientsareassociatedwiththeirworseprognosisduetotheimpairmentoftcellresponses AT jacintoantonio circulatinglowdensityneutrophilsofbreastcancerpatientsareassociatedwiththeirworseprognosisduetotheimpairmentoftcellresponses AT bragasofia circulatinglowdensityneutrophilsofbreastcancerpatientsareassociatedwiththeirworseprognosisduetotheimpairmentoftcellresponses AT cabralmguadalupe circulatinglowdensityneutrophilsofbreastcancerpatientsareassociatedwiththeirworseprognosisduetotheimpairmentoftcellresponses |